India to Myanmar: Clindamycin Export Trade Route
India has recorded 23 verified shipments of Clindamycin exported to Myanmar, representing a combined trade value of $3.1M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $134.5K USD. The leading Indian exporter is MULTICO EXPORTS PRIVATE LIMITED, which accounts for 98% of total export value with 4 shipments worth $3.0M USD. On the buying side, LEGEND CREATIVES CO. LTD. is the largest importer in Myanmar with $3.0M USD in purchases. The top 3 suppliers — MULTICO EXPORTS PRIVATE LIMITED, MULTICO EXPORTS PRIVATE LIMITED , SOFTGEL HEALTHCARE PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Clindamycin corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $3.1M USD. The route is dominated by MULTICO EXPORTS PRIVATE LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $134.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 14.6%, placing it at rank #5 among India's top clindamycin export destinations globally.
On the import side, key buyers of Indian clindamycin in Myanmar include LEGEND CREATIVES CO. LTD., LEGEND CREATIVES CO. LTD. , LEGEND CREATIVES CO LIMITED and 15 others. LEGEND CREATIVES CO. LTD. is the single largest importer with 2 shipments valued at $3.0M USD.
